Ranolazine

Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study

A Study of Ranolazine in ALS

Feasibility Trial for a Right Ventricular Failure Platform Trial

Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries

Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients

A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy

Ranolazine a Potential New Therapeutic Application

Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)

Ranolazine Mediated PVC Reduction in Ischemic Heart Disease

CiPA Phase 1 ECG Biomarker Validation Study

The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

Ranolazine Among Unrevascularized Chronic Stable Angina Patients

Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction

Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents

Microvascular Coronary Disease In Women: Impact Of Ranolazine

Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)

Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia